About Us


Arbor Pharmaceuticals is led by a team of skilled pharmaceutical veterans, many of whom have experience as healthcare practitioners. Our people fully understand the pharmaceutical development process and the value our products can bring to the lives of patients. The Arbor team is now over 300 strong and has full knowledge and capabilities in pharmaceutical development, manufacturing, quality control and commercialization. We work with numerous partners throughout the world for the licensing, development, and manufacturing of our marketed and late-stage pipeline products.

Over the past ten years, management has transformed Arbor into a fully integrated pharmaceutical company focused on the therapeutic areas of cardiology, neurology, endocrinology, and orphan products. We have built a strong foundation of clinically differentiated marketed and pipeline products to successfully compete in the pharmaceutical industry. Arbor currently markets twenty FDA approved products with several more in development.

The Arbor Board is comprised of several individuals that have founded, created, and led pharmaceutical companies ranging in value from several hundred million to over six billion dollars in market value. Our board and management team remain committed to building a company that keeps patients first and adds value to society.


Arbor Pharmaceuticals is an Atlanta, Georgia based specialty pharmaceutical company which currently markets prescription products for the cardiovascular, neurology, endocrinology, and orphan markets. In addition, Arbor has several branded prescription products in late-stage development. We also market several generic products through our Wilshire Division (www.wilshirerx.com).

We believe that our strongest asset is our people and have hired industry veterans with pharmaceutical knowledge and experience across most therapeutic areas and in all stages of development, manufacturing, and commercialization. Our goal is to license and develop products that will improve, extend, and even save lives. Arbor is committed to bringing safe and effective medicines to the market as well as the services and support that contribute to healthy outcomes.

Arbor is proud to be a corporate sponsor of a number of nonprofit organizations in our current therapeutic areas. We believe in being a good corporate citizen by doing our part to help associations and foundations that focus on funding discovery of new medicines or helping people afflicted by diseases that our products treat. The entire Arbor team is dedicated to creating value for our patients and shareholders by bringing improved medicines to the market with a focus on quality.


Arbor Pharmaceuticals and its partners have multiple projects under various stages of development. We develop both new chemical entities as well as already approved molecules for new indications or in improved dosage forms. Our research scientists have extensive experience in clinical development and work collaboratively with the FDA to obtain market approval. The company has received approval for four New Drug Applications (NDAs) from the FDA to date and has additional products in late-stage development. Link to the Product Pipeline page to see the projects currently in clinical development.